Application of Antimicrobial Peptide LL-37 as an Adjuvant for Middle East Respiratory Syndrome-Coronavirus Antigen Induces an Efficient Protective Immune Response Against Viral Infection After Intranasal Immunization

The human antimicrobial peptide LL-37 has chemotactic and modulatory activities in various immune cells, including dendritic cells. Because of its characteristics, LL-37 can be considered an adjuvant for vaccine development. In this study, we confirmed the possible adjuvant activity of LL-37 in muco...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ju, Yang, Ye Lin, Jeong, Yongsu, Jang, Yong-Suk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Immunologists 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634147/
https://www.ncbi.nlm.nih.gov/pubmed/36381960
http://dx.doi.org/10.4110/in.2022.22.e41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634147/
https://www.ncbi.nlm.nih.gov/pubmed/36381960
http://dx.doi.org/10.4110/in.2022.22.e41

Ejemplares similares